Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations

doi:10.3748/wjg.v12.i17.2742

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 17

This Article

(0)

(9062)

(8)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Basic Research

World J Gastroenterol. May 7, 2006; 12(17): 2742-2748
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2742

Full Size Figure Download Figure

Figure 1 Chromatograms of spiked plasma sample (B), plasma samples of patients before (A) and after (C) the administration of 200 mg ranitidine. M1 and M2 are metabolites of ranitidine.

Citation: Zhou Q, Ruan ZR, Yuan H, Jiang B, Xu DH. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. World J Gastroenterol 2006; 12(17): 2742-2748
URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2742.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i17.2742

Zhou Q, Ruan ZR, Yuan H, Jiang B, Xu DH. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. World J Gastroenterol 2006; 12(17): 2742-2748 [PMID: 16718762 DOI: 10.3748/wjg.v12.i17.2742]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.